CUMBERLAND PHARMACEUTICALS INC (CPIX)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 20M 40M 60M Q3 '16: 32M Q4 '16: 33M Q1 '17: 34.9M Q2 '17: 36.2M Q3 '17: 38.6M Q4 '17: 40.4M Q1 '18: 39.3M Q2 '18: 40.8M Q3 '18: 38.1M Q4 '18: 28.8M Q1 '19: 28.9M Q2 '19: 28.2M Q3 '19: 26.6M Q4 '19: 32.4M Q1 '20: 32M Q2 '20: 32.2M Q3 '20: 34.5M Q4 '20: 35.8M Q1 '21: 38M Q2 '21: 37.5M Q3 '21: 36.3M Q4 '21: 35M Q1 '22: 35.7M Q2 '22: 36.9M Q3 '22: 40.3M Q4 '22: 42M Q1 '23: 40.1M Q2 '23: 40.7M Q3 '23: 39.3M Q4 '23: 39.6M Q1 '24: 38.8M Q2 '24: 37.8M Q3 '24: 36.8M Q4 '24: 37.9M Q1 '25: 41.1M Q2 '25: 42.1M Q3 '25: 41.3M Q4 '25: 44.5M Q1 '26: 41.9M Q2 '26: 39.9M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Gross Profit TTM

0 15M 30M 45M Q2 '18: 33.5M Q3 '18: 31.5M Q4 '18: 22.8M Q1 '19: 22.8M Q2 '19: 21.8M Q3 '19: 20.1M Q4 '19: 25M Q1 '20: 24.6M Q2 '20: 24M Q3 '20: 25.7M Q4 '20: 27.2M Q1 '21: 28.6M Q2 '21: 28.9M Q3 '21: 28.6M Q4 '21: 26.2M Q1 '22: 27.1M Q2 '22: 28M Q3 '22: 30.5M Q4 '22: 32.9M Q1 '23: 31.9M Q2 '23: 33M Q3 '23: 32.1M Q4 '23: 33.5M Q1 '24: 32.4M Q2 '24: 31.2M Q3 '24: 30.6M Q4 '24: 31.3M Q1 '25: 34.6M Q2 '25: 35.3M Q3 '25: 34.9M Q4 '25: 37.9M Q1 '26: 34.8M Q1 '19 Q1 '20 Q1 '21 Q1 '22 Q1 '23 Q1 '24 Q1 '25 Q1 '26

Revenue minus cost of sales. This filer tags no gross profit of its own..

Operating Income TTM

-12M -8M -4M 0 4M 8M 12M Q3 '16: -313.1K Q4 '16: -1.4M Q1 '17: -1.6M Q2 '17: -3.2M Q3 '17: -4.1M Q4 '17: -4.1M Q1 '18: -5.9M Q2 '18: -5.1M Q3 '18: -6M Q4 '18: -8.4M Q1 '19: -7.3M Q2 '19: -7.8M Q3 '19: -9.2M Q4 '19: -9.3M Q1 '20: -9.8M Q2 '20: -10M Q3 '20: -8M Q4 '20: -6.4M Q1 '21: -4.9M Q2 '21: -4.7M Q3 '21: -5.1M Q4 '21: -7.7M Q1 '22: -8.6M Q2 '22: -9.1M Q3 '22: -7.8M Q4 '22: -5.7M Q1 '23: -5.9M Q2 '23: -4.1M Q3 '23: -5.7M Q4 '23: -9.6M Q1 '24: -9.9M Q2 '24: -10.9M Q3 '24: -10.8M Q4 '24: -6.4M Q1 '25: -3.3M Q2 '25: -5.4M Q3 '25: -5.6M Q4 '25: -5.2M Q1 '26: -9.6M Q2 '26: -9.6M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Net Income TTM

-12M -8M -4M 0 4M 8M 12M Q3 '16: -43.9K Q4 '16: -944.7K Q1 '17: -2M Q2 '17: -7.1M Q3 '17: -7.9M Q4 '17: -8M Q1 '18: -9.1M Q2 '18: -4.6M Q3 '18: -5.5M Q4 '18: -7M Q1 '19: -4.7M Q2 '19: -4.5M Q3 '19: -4.8M Q4 '19: -3.5M Q1 '20: -4.5M Q2 '20: -4.9M Q3 '20: -3.4M Q4 '20: -3.3M Q1 '21: -2.1M Q2 '21: 29.9K Q3 '21: -543.7K Q4 '21: -3.5M Q1 '22: -5.1M Q2 '22: -7.6M Q3 '22: -7M Q4 '22: -5.6M Q1 '23: -4M Q2 '23: -1.8M Q3 '23: -2.4M Q4 '23: -6.3M Q1 '24: -8.4M Q2 '24: -10.4M Q3 '24: -10.9M Q4 '24: -6.5M Q1 '25: -3.3M Q2 '25: -2.9M Q3 '25: -3.3M Q4 '25: -2.8M Q1 '26: -7.4M Q2 '26: -10.9M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Cost of Revenue TTM

0 3.5M 7M 10.5M Q2 '18: 7.4M Q3 '18: 6.7M Q4 '18: 6M Q1 '19: 6.1M Q2 '19: 6.4M Q3 '19: 6.5M Q4 '19: 7.4M Q1 '20: 7.4M Q2 '20: 8.2M Q3 '20: 8.8M Q4 '20: 8.7M Q1 '21: 9.4M Q2 '21: 8.6M Q3 '21: 7.8M Q4 '21: 8.8M Q1 '22: 8.6M Q2 '22: 8.9M Q3 '22: 9.8M Q4 '22: 9.1M Q1 '23: 8.2M Q2 '23: 7.6M Q3 '23: 7.2M Q4 '23: 6.1M Q1 '24: 6.4M Q2 '24: 6.6M Q3 '24: 6.1M Q4 '24: 6.6M Q1 '25: 6.4M Q2 '25: 6.7M Q3 '25: 6.4M Q4 '25: 6.7M Q1 '26: 7.2M Q1 '19 Q1 '20 Q1 '21 Q1 '22 Q1 '23 Q1 '24 Q1 '25 Q1 '26

Operating Cash Flow TTM

-3.5M 0 3.5M 7M 10.5M Q3 '16: 1.1M Q4 '16: 569.5K Q1 '17: 1.4M Q2 '17: 22.4K Q3 '17: 721.6K Q4 '17: -557.7K Q1 '18: -1.8M Q2 '18: 1.6M Q3 '18: -1.1M Q4 '18: 3.1M Q1 '19: 2.5M Q2 '19: 3.5M Q3 '19: 5.9M Q4 '19: 3.1M Q1 '20: 4.3M Q2 '20: 5.3M Q3 '20: 5.4M Q4 '20: 5.4M Q1 '21: 6.3M Q2 '21: 6.2M Q3 '21: 5.2M Q4 '21: 6.3M Q1 '22: 4.4M Q2 '22: 4M Q3 '22: 6.8M Q4 '22: 8.5M Q1 '23: 7.2M Q2 '23: 10.1M Q3 '23: 8.7M Q4 '23: 6.1M Q1 '24: 5.4M Q2 '24: -715.6K Q3 '24: -1.5M Q4 '24: -612.2K Q1 '25: 5.4M Q2 '25: 7.1M Q3 '25: 6.8M Q4 '25: 4.9M Q1 '26: 1.4M Q2 '26: 746K Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Free Cash Flow TTM

-2.5M 0 2.5M 5M 7.5M Q3 '15: 7.2M Q4 '15: 5.7M Q1 '16: 4.3M Q2 '16: 1.1M Q3 '16: 928.6K Q4 '16: 438.6K Q1 '17: 1.2M Q2 '17: -181.1K Q3 '17: 516.1K Q4 '17: -833.7K Q1 '18: -2M Q2 '18: 1.3M Q3 '18: -1.3M Q4 '18: 2.7M Q1 '19: 2.1M Q2 '19: 3.1M Q3 '19: 5.5M Q4 '19: 2.8M Q1 '20: 4.1M Q2 '20: 5.1M Q3 '20: 5.2M Q4 '20: 5.3M Q1 '21: 6.2M Q2 '21: 6.1M Q3 '21: 5.1M Q4 '21: 6.2M Q1 '22: 4.3M Q2 '22: 3.8M Q3 '22: 6.5M Q4 '23: 5.8M Q1 '24: 5.2M Q2 '24: -866.3K Q3 '24: -1.6M Q4 '24: -678.6K Q1 '25: 5.4M Q2 '25: 7M Q3 '25: 6.7M Q4 '25: 4.8M Q1 '26: 1.4M Q2 '26: 683.9K Q3 '16 Q4 '17 Q1 '19 Q2 '20 Q3 '21 Q4 '23 Q1 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 7M 14M 21M Q2 '13: 18.4M Q3 '13: 18.2M Q1 '14: 18.2M Q2 '14: 18M Q3 '14: 17.8M Q1 '15: 17.4M Q2 '15: 17.2M Q3 '15: 17M Q1 '16: 16.3M Q2 '16: 16.2M Q3 '16: 16.5M Q1 '17: 16M Q2 '17: 16M Q3 '17: 15.9M Q1 '18: 15.7M Q2 '18: 15.7M Q3 '18: 15.6M Q1 '19: 15.9M Q2 '19: 15.5M Q3 '19: 15.4M Q1 '20: 15.6M Q2 '20: 15.2M Q3 '20: 15.1M Q1 '21: 15.2M Q2 '21: 15.1M Q3 '21: 14.9M Q1 '22: 14.7M Q2 '22: 14.7M Q3 '22: 14.5M Q1 '23: 14.6M Q2 '23: 14.6M Q3 '23: 14.3M Q1 '24: 14.1M Q2 '24: 14.1M Q3 '24: 14.1M Q1 '25: 15.3M Q2 '25: 15M Q3 '25: 15M Q1 '26: 15M Q2 '26: 15M Q3 '14 Q2 '16 Q1 '18 Q3 '19 Q2 '21 Q1 '23 Q3 '24 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-0.90 -0.60 -0.30 0.00 0.30 0.60 0.90 Q3 '16: 0.00 Q4 '16: -0.06 Q1 '17: -0.12 Q2 '17: -0.44 Q3 '17: -0.50 Q4 '17: -0.50 Q1 '18: -0.57 Q2 '18: -0.30 Q3 '18: -0.36 Q4 '18: -0.45 Q1 '19: -0.30 Q2 '19: -0.29 Q3 '19: -0.31 Q4 '19: -0.23 Q1 '20: -0.30 Q2 '20: -0.32 Q3 '20: -0.22 Q4 '20: -0.22 Q1 '21: -0.14 Q2 '21: 0.00 Q3 '21: -0.04 Q4 '21: -0.24 Q1 '22: -0.34 Q2 '22: -0.51 Q3 '22: -0.47 Q4 '22: -0.38 Q1 '23: -0.28 Q2 '23: -0.13 Q3 '23: -0.17 Q4 '23: -0.44 Q1 '24: -0.59 Q2 '24: -0.73 Q3 '24: -0.77 Q4 '24: -0.47 Q1 '25: -0.25 Q2 '25: -0.22 Q3 '25: -0.24 Q4 '25: -0.19 Q1 '26: -0.49 Q2 '26: -0.73 Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.